Sanofi builds on its top spot in flu vaccines with $200M plant investment

Fierce Pharma -------- Sanofi’s flu vaccines are the top-selling in the world. To meet demand for its newest four-in-one flu shot, the drugmaker will invest more than $200 million in a new plant in France to produce it. The French drugmaker today announced (PDF) the plans for the €170 million facility, saying it would be erected at its Val de Reuil manufacturing site about 100 kilometers northwest of Paris. To learn more click on the picture below to read the article.